In the upcoming Budget 2024, the Indian government is expected to introduce a comprehensive new scheme aimed at boosting medical device manufacturing, enhancing the quality of products, and reducing the country's reliance on imports. This move is a part of the broader strategy to strengthen the domestic manufacturing sector and ensure the availability of high-quality medical devices within the country.

Scheme Overview

The anticipated scheme may include several key initiatives to improve the regulatory framework and quality standards in the medical device industry. Post-market surveillance and regulatory streamlining are expected to be major components, ensuring that medical devices in the market meet stringent quality and safety standards. Additionally, the scheme might mandate clinical evaluations of medical devices to verify their efficacy and safety before they are approved for widespread use.

The focus on regulatory improvements aims to facilitate a more efficient approval process for new medical devices, thus encouraging innovation and quicker market entry. By streamlining regulations, the government hopes to reduce bureaucratic delays and foster a more supportive environment for manufacturers.

Impact on Manufacturing and Quality

The new scheme is designed to strengthen the manufacturing capabilities within India. By providing a clear regulatory pathway and supporting infrastructure, the government aims to attract investments in the medical device sector. This will not only upgrade the quality of domestically produced medical devices but also reduce the dependence on imports.

As of FY24, India’s medical device imports stand at $8.18 billion, while exports are at $3.8 billion. The significant gap between imports and exports highlights the need for enhanced domestic production capabilities. The proposed scheme is expected to address this by encouraging local manufacturing, thus reducing the import bill and increasing export potential.

Proposed Policy Measures

The government is also considering introducing a marketing practice code and price controls for medical devices to ensure that prices are kept in check and that manufacturers adhere to ethical marketing practices. These measures are aimed at protecting consumers and ensuring that medical devices remain affordable while maintaining high quality.

Currently, the Finance Ministry is still evaluating the contours of the new scheme, and nothing has been finalized yet. The detailed framework and specific initiatives will be outlined in the Budget 2024, expected to be presented in the upcoming fiscal year.

National Pension System Update

In addition to the focus on medical device manufacturing, the Budget 2024 is also likely to address concerns related to the National Pension System (NPS) for central government employees. The government is considering offering 50% of the last salary drawn as a pension under the NPS. This move is seen as a response to concerns raised by employees regarding the adequacy of retirement benefits under the current system.

A panel led by Finance Secretary TV Somanathan has been assessing the impact of providing an assured return. The committee's recommendations, expected to be included in the Budget, suggest offering a 50% guarantee on the last salary drawn, with the government covering any shortfall. This proposal aims to provide more financial security to central government employees post-retirement.

About the National Pension System

The National Pension System (NPS) is a voluntary, long-term retirement savings scheme regulated by the Pension Fund Regulatory and Development Authority (PFRDA). It operates on a defined contribution basis, where subscribers contribute regularly towards their retirement account during their working years. The accumulated corpus is invested in various financial instruments such as equity, corporate bonds, government securities, and alternative assets.

The NPS offers significant tax benefits under Section 80C of the Income Tax Act and provides an additional deduction under Section 80CCD(1B). Managed by Pension Fund Managers (PFMs) appointed by the PFRDA, the NPS aims to provide financial security to individuals during their post-retirement period.

In conclusion, the Budget 2024 is expected to introduce a series of measures aimed at boosting medical device manufacturing and ensuring the financial security of central government employees. These initiatives reflect the government's commitment to enhancing domestic production capabilities, improving regulatory standards, and addressing key concerns related to retirement benefits. As more details emerge, stakeholders will be keenly watching the Budget announcements for specific policy measures and their potential impact on the industry and workforce.

Also Read : Indian Stock Market Falls as Investors Book Profits in Key Heavyweight Stocks

Join our Trading with CA Abhay Telegram Channel for regular Stock Market Trading and Investment Calls by CA Abhay Varn - SEBI Registered Research Analyst & Finance Saathi Telegram Channel for Regular Share Market, News & IPO Updates

Start your Stock Market Journey and Apply in IPO by Opening Free Demat Account in Choice Broking FinX & Upstox.